Fang Tonghua, deputy to the National People's Congress, said the construction of a TCM clinical evaluation system could inject vitality into TCM research and innovation

2021-03-09 15:35:00
  "China attaches great importance to the development of traditional Chinese medicine, and has formulated a series of laws and policies to encourage and support the innovative development of traditional Chinese medicine. However, there is still a weak basis for the evaluation of traditional Chinese medicine resources and a lack of authoritative research and evaluation platforms and achievements at the national level."Fang Tonghua, a deputy to the National People's Congress and chairman of Heilongjiang ZBD Pharmaceutical Co., Ltd., pays close attention to the development of TCM.

   According to Fang, there are still obvious deficiencies in TCM evaluation system, quality control and basic research in China, mainly due to the unsound clinical evaluation system of TCM. In this regard, Fang suggested that a TCM clinical evaluation system should be established to provide policy, legal and institutional support and guarantee for TCM innovation. In addition, according to the needs of TCM innovation research, the "control drugs" list of TCM should be formulated at the national level to promote the actual implementation of TCM research and development. 
 
   "It is also necessary to carry out comprehensive research on classic Chinese medicine prescriptions."'We should speed up the study of famous classical formulas, guide TCM research institutions, organize TCM masters and Qishan scholars from TCM universities, and provide comprehensive work guidance and support for the development of TCM products in terms of theory, dosage and quality,' Mr. Fang said.